Using innovative techniques for analyzing single cells (scRNAseq), Professor Peleg Hasson and doctoral student Wesal Yaseen Badarneh reexamined the classical view of distinct identities for the tissues composing the musculoskeletal system. They identified a novel cluster of cells, which they termed dual identity cells. These dual identity cells are fibroblast-derived, yet express myogenic transcriptional programs and fuse into the tips of the developing muscle fibers along the muscle tendon junctions, facilitating the introduction of fibroblast-specific transcripts into the elongating myofibers.
Tendons are the connective tissues that connect between the muscles and bones. Consequently, the tendons’ mechanical properties are crucial in order for humans and other vertebrates to bear varying pressures and perform essential movements. When the development of MTJs is damaged, it may result in clinical phenomena including multiple types of muscle diseases. Therefore understanding the molecular mechanism underlying MTJ development is very important.
Although vertebrate muscles and tendons are derived from distinct embryonic origins, they must interact in order to enable muscle contraction and body movements. It is still not understood how these two distinct tissues, each with its own biophysical and biochemical properties, form robust junctions that are able to withstand contraction forces. Prof. Hasson and his team identified fibroblasts that have switched on a myogenic program facilitating a seamless transition from a muscle fiber characteristic into a tendon-like structure. Their findings suggest that dual characteristics of junctional cells could be a common mechanism for generating stable interactions between tissues throughout the musculoskeletal system.
The research was carried out in collaboration with researchers from the University of Cincinnati College of Medicine and the Cincinnati Children’s Hospital Medical Center. It was supported by the Israel Science Foundation, the Rappaport Family Institute at Technion, Pew Charitable Trusts, and the National Institutes of Health (NIH).
For more than a century, the Technion – Israel Institute of Technology has pioneered in science and technology education and delivered world-changing impact. Proudly a global university, the Technion has long leveraged boundary-crossing collaborations to advance breakthrough research and technologies. Now with a presence in three countries, the Technion will prepare the next generation of global innovators. Technion people, ideas and inventions make immeasurable contributions to the world, innovating in fields from cancer research and sustainable energy to quantum computing and computer science to do good around the world.
The American Technion Society supports visionary education and world-changing impact through the Technion – Israel Institute of Technology. Based in New York City, we represent thousands of US donors, alumni and stakeholders who invest in the Technion’s growth and innovation to advance critical research and technologies that serve the State of Israel and the global good. Since 1940, our nationwide supporter network has funded new Technion scholarships, research, labs, and facilities that have helped deliver world-changing contributions and extend Technion education to campuses in three countries.